Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden
Uta Oelschlaegel(University Hospital Carl Gustav Carus), Uwe Platzbecker(National Center for Tumor Diseases), Martin Bornhäuser(Technische Universität Dresden), Maximilian Alexander Röhnert(University Hospital Carl Gustav Carus), Katja Sockel(Innsbruck Medical University), Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Christian Thiede(University Hospital Carl Gustav Carus), Sylvia Herold(University Hospital Carl Gustav Carus), Gerhard Ehninger(University Hospital Carl Gustav Carus)
Cited by 9
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k